Chevaux JB - Search Results

1

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.

Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, Carbonnel F, Colombel JF, Dupas JL, Godeberge P, Hugot JP, Lémann M, Nahon S, Sabaté JM, Tucat G, Beaugerie L; Cesame Study Group. Peyrin-Biroulet L, et al. Among authors: chevaux jb. Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25. Gastroenterology. 2011. PMID: 21708105

2

Optimizing thiopurine therapy in inflammatory bowel disease.

Chevaux JB, Peyrin-Biroulet L, Sparrow MP. Chevaux JB, et al. Inflamm Bowel Dis. 2011 Jun;17(6):1428-35. doi: 10.1002/ibd.21494. Epub 2010 Oct 14. Inflamm Bowel Dis. 2011. PMID: 20949566 Review.

3

Risk of melanoma in patients who receive thiopurines for inflammatory bowel disease is not increased.

Peyrin-Biroulet L, Chevaux JB, Bouvier AM, Carrat F, Beaugerie L. Peyrin-Biroulet L, et al. Among authors: chevaux jb. Am J Gastroenterol. 2012 Sep;107(9):1443-4. doi: 10.1038/ajg.2012.181. Am J Gastroenterol. 2012. PMID: 22951883 No abstract available.

4

Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France.

Chevaux JB, Nani A, Oussalah A, Venard V, Bensenane M, Belle A, Gueant JL, Bigard MA, Bronowicki JP, Peyrin-Biroulet L. Chevaux JB, et al. Inflamm Bowel Dis. 2010 Jun;16(6):916-24. doi: 10.1002/ibd.21147. Inflamm Bowel Dis. 2010. PMID: 19885908

5

Predictors of infliximab failure after azathioprine withdrawal in Crohn's disease treated with combination therapy.

Oussalah A, Chevaux JB, Fay R, Sandborn WJ, Bigard MA, Peyrin-Biroulet L. Oussalah A, et al. Among authors: chevaux jb. Am J Gastroenterol. 2010 May;105(5):1142-9. doi: 10.1038/ajg.2010.158. Epub 2010 Apr 13. Am J Gastroenterol. 2010. PMID: 20389296

6

Herpes simplex virus colitis complicating the course of a patient with Crohn's disease and cirrhosis: an underestimated association?

Chevaux JB, Peyrin-Biroulet L. Chevaux JB, et al. Gastroenterol Hepatol (N Y). 2010 Feb;6(2):122-4. Gastroenterol Hepatol (N Y). 2010. PMID: 20567556 Free PMC article. No abstract available.

7

Is the dose of thioguanine the key to better safety profile?

Chevaux JB, Peyrin-Biroulet L. Chevaux JB, et al. Dig Liver Dis. 2011 Feb;43(2):96-7. doi: 10.1016/j.dld.2010.11.003. Epub 2010 Dec 14. Dig Liver Dis. 2011. PMID: 21156354 No abstract available.

8

Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.

Bouguen G, Chevaux JB, Peyrin-Biroulet L. Bouguen G, et al. Among authors: chevaux jb. World J Gastroenterol. 2011 Feb 7;17(5):547-56. doi: 10.3748/wjg.v17.i5.547. World J Gastroenterol. 2011. PMID: 21350703 Free PMC article. Review.

9

Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: a worldwide survey of experts.

Roblin X, Oussalah A, Chevaux JB, Sparrow M, Peyrin-Biroulet L. Roblin X, et al. Among authors: chevaux jb. Inflamm Bowel Dis. 2011 Dec;17(12):2480-7. doi: 10.1002/ibd.21662. Epub 2011 Feb 23. Inflamm Bowel Dis. 2011. PMID: 21351210

10

Dietary beliefs and behavior among inflammatory bowel disease patients.

Zallot C, Quilliot D, Chevaux JB, Peyrin-Biroulet C, Guéant-Rodriguez RM, Freling E, Collet-Fenetrier B, Williet N, Ziegler O, Bigard MA, Guéant JL, Peyrin-Biroulet L. Zallot C, et al. Among authors: chevaux jb. Inflamm Bowel Dis. 2013 Jan;19(1):66-72. doi: 10.1002/ibd.22965. Inflamm Bowel Dis. 2013. PMID: 22467242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page